** = Publications listed in SCI/SSCI/Pubmed
** Griesbacher, T
Towards European training regulations for medical specialists in (clinical) pharmacology in Europe: interim report
N-S ARCH PHARMACOL. 2019; 392: S59-S59.
[Poster]
Web of Science
** Griesbacher, T
Recognition and training of specialists in Clinical Pharmacology in europe: A pilot survey of the UEMS section of pharmacology
N-S ARCH PHARMACOL. . 2018; 391: S57-S57.-84th Annual Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology (DGPT) / 20th Annual Meeting of the Association-of-the-Clinical-Pharmacology-Germany (VKliPha); FEB 26-MAR 01, 2018; Gottingen, GERMANY.
[Oral Communication]
Web of Science
** Griesbacher, T
ACTIVITIES OF EPHAR, EACPT AND UEMS TO SUPPORT TRAINING OF BASIC AND CLINICAL PHARMACOLOGISTS IN EUROPE
BASIC CLIN PHARMACOL. . 2018; 123: 4-4.-1st Meeting in Translational Pharmacology, 38th SEF national meeting/9th SEFF meeting; JUN 19-20, 2018; Santiago de Compostela, SPAIN.
[Oral Communication]
Web of Science
** Griesbacher, T
The European Certified Pharmacologists (EuCP) program: establishing common standards for postgraduate professional training in pharmacology
N-S ARCH PHARMACOL. 2015; 388: S60-S60.-81st Annual Meeting of the Deutsche-Gesellschaft-für-Experimentelle-und-Klinische-Pharmakologie-und-Toxikologie-e-V; MAR 10-12, 2015; Kiel, GERMANY.
[Poster]
Web of Science
** Griesbacher, T; Holzer, U; Smolle, J; Heinemann, A; Peskar, BA
Pharmacology e-learning in an integrated undergraduate curriculum of human medicine
Naunyn-Schmiedeberg's Arch. Pharmacol.2011; 383(S. 1):81--77. Frühjahrstagung der Deutschen Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie; MAR 30 - APR 1, 2011; Frankfurt am Main, GERMANY.
[Poster]
Web of Science
FullText
** Griesbacher, T; Pommer, V; Schuligoi, R; Tiran, B; Peskar, BA
Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis.
Int Immunopharmacol. 2008; 8(2): 325-329.
Doi: 10.1016/j.intimp.2007.08.005
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Rainer, I; Tiran, B; Peskar, BA
Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.
Br J Pharmacol. 2008; 155(6): 865-874.
Doi: 10.1038/bjp.2008.321
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Pommer, V; Schuligoi, R; Tiran, B; Peskar, BA
Differential anti-inflammatory properties of peroxisome proliferator-activated receptors (PPAR) alpha and gamma in cerulein-induced pancreatitis
PANCREAS. 2007; 35(4):403-404.-American Pancreatic Association Annual Meeting 2007; Nov 1-3, 2007; Chicago, IL, USA.
Doi: 10.1097/01.mpa.0000297705.75724.76
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Griesbacher, T; Tiran, B; Peskar, BA
Possible role of peroxisome proliferator-activated receptor alpha (Ppar-alpha) in anti-inflammatory actions of perfluorooctanoid acid (Pfoa) in experimental acute pancreatitis
GASTROENTEROLOGY. 2007; 132(4): A253-A253.
[Poster]
Web of Science
** Griesbacher, T; Rainer, I; Heinemann, A; Groisman, D
Haemodynamic and exocrine effects of caerulein at submaximal and supramaximal levels on the rat pancreas: role of cholecystokinin receptor subtypes.
Pancreatology. 2006; 6(1-2):65-75
Doi: 10.1159/000090025
Web of Science
PubMed
FullText
FullText_MUG
** Lerch, MM; Griesbacher, T; Whitcomb, DC
Molecular basis of inherited pancreatic disorders - Preface
ENDOCRINOL METAB CLIN N AMER 2006 35: -.
Doi: 10.1016/j.ecl.2006.03.001
Web of Science
FullText
FullText_MUG
** Lerch, MM; Griesbacher, T; Whitcomb, DC
The 5th International Symposium on Inherited Diseases of the Pancreas.
Pancreatology. 2006; 6(4):414-416
Doi: 10.1159/000094318
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Evans, DM; Peskar, BA
Selective kallikrein inhibitors attenuate hemorrhagic lesions caused by kinin antagonists in experimental acute pancreatitis
ACTA PHARMACOL SIN. 2006; 27: 279-280.-15th World Congress of Pharmacology; JUL 2-7, 2006; Beijing, CHINA.
[Poster]
Web of Science
** Griesbacher, T; Peskar, BA
Effects of perfluorooctanoic acid (PFOA) in cerulein-induced acute pancreatitis in rats.
Pancreas. 33: 464-464.-Joint Meeting of the American Pancreatic Association and the International Association of Pancreatology; NOV 1-4, 2006; Chicago, IL, USA.
Doi: 10.1097/00006676-200611000-00096
[Poster]
Web of Science
FullText
FullText_MUG
** Griesbacher, T; Evans, DM; Peskar, BA
Selective kallikrein inhibitors attenuate haemorrhagic laesions caused by kinin antagonists in experimental acute pancreatitis
PHARMACOLOGY. 2005; 75: 198-198.-11th Symposium of the Austrian-Pharmacological-Society (Joint Meeting with the Austrian Society of Toxicology and the Hungarian Society for Experimental and Clinical Pharmacology); NOV 24-26, 2005; Vienna, AUSTRIA.
Web of Science
** Griesbacher, T; Rainer, I; Schuligoi, R; Peskar, BA
Independence of prostaglandin formation and the inflammatory oedema during caerulein-induced acute pancreatitis in rats
PHARMACOLOGY 2004 72: 135-135.
[Poster]
Web of Science
** Griesbacher, T; Schuligoi, R; Peskar, BA
Prostaglandin formation and bradykinin-mediated edema formation during cerulein-induced acute pancreatitis in rats
GASTROENTEROLOGY. 2004; 126(4): A525-A526.
Web of Science
** Griesbacher, T; Rainer, I; Tiran, B; Fink, E; Lembeck, F; Peskar, BA
Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.
Br J Pharmacol. 2003; 139(2):299-308
Doi: 10.1038/sj.bjp.0705247
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Rainer, I; Heinemann, A; Groisman, D
Changes in blood flow in the rat pancreas during exocrine stimulation at submaximal and supramaximal levels
BRIT J PHARMACOL 2003 138: U33-U33.
Web of Science
** Groisman, D; Griesbacher, T
In vivo characterization of the cholecystokinin CCK1 receptor agonist SR146131 in the rat pancreas
PHARMACOLOGY 2003 69: 214-214.
Web of Science
** Griesbacher, T; Rainer, I; Tiran, B; Evans, DM
Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats.
Br J Pharmacol. 2002; 137(5):692-700
Doi: 10.1038/sj.bjp.0704910
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Griesbacher, T; Schicho, R; Althuber, P; Schuligoi, R; Kerl, H; Wolf, P
Repeated subinflammatory ultraviolet B irradiation increases substance P and calcitonin gene-related peptide content and augments mustard oil-induced neurogenic inflammation in the skin of rats.
Neurosci Lett. 2002; 329(3):309-313
Doi: 10.1016/S0304-3940(02)00428-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Peskar, BA; Rainer, I; Fink, E; Evans, DM
Mechanisms of kinin release during acute cerulein-induced pancreatitis
GASTROENTEROLOGY 2001 120: A538-A538.
Web of Science
** Griesbacher, T
Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors.
Pharmacology. 2000; 60(3):113-120
Doi: 10.1159/000028355
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Legat, FJ
Effects of the non-peptide B2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation.
Inflamm Res. 2000; 49(10):535-540
Doi: 10.1007/s000110050628
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Rainer, I
5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
Immunopharmacology. 1999; 43(2-3):195-201
Doi: 10.1016%2FS0162-3109%2899%2900103-4
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Rainer, I; Evans, DM
Inhibition of kinin action and kinin generation compared to dexamethasone pretreatment with respect to vascular effects and pancreatic enzymes in experimental acute pancreatitis.
Immunopharmacology. 1999; 43(2-3):219-224
Doi: 10.1016%2FS0162-3109%2899%2900093-4
Web of Science
PubMed
FullText
FullText_MUG
** Legat, FJ; Griesbacher, T; Althuber, P; Schuligoi, R; Kerl, H; Wolf, P
UVB irradiation with non-erythematogenic doses increases neuropeptides in the skin of rat ears.
PHOTOCHEM PHOTOBIOL 1999 69: 55S-55S.
Web of Science
** Griesbacher, T; Althuber, P; Zenz, M; Rainer, I; Griengl, S; Lembeck, F
Vespula vulgaris venom: role of kinins and release of 5-hydroxytryptamine from skin mast cells.
Eur J Pharmacol. 1998; 351(1):95-104
Doi: 10.1016/S0014-2999(98)00276-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Amann, R; Sametz, W; Diethart, S; Juan, H
The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception.
Br J Pharmacol. 1998; 124(6):1328-1334
Doi: 10.1038/sj.bjp.0701938
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Lembeck, F; Burchert, M; Peskar, BA
Role of the kinin-mediated edema for the accumulation of kinins in the pancreas in experimental pancreatitis.
GASTROENTEROLOGY 1998 114: A464-A464.
Doi: 10.1016/S0016-5085(98)81875-1
Web of Science
FullText
FullText_MUG
** Griesbacher, T; Rainer, I
Differential effects of a bradykinin B-2 receptor antagonist and dexamethasone on accumulation of activated enzymes during acute pancreatitis
NAUNYN-SCHMIED ARCH PHARMACOL 1998 358: R348-R348.
Web of Science
** Griesbacher, T; Tiran, B; Sutliff, RL
Accumulation of lysophospholipids in the pancreas of rats during and after cerulein-induced acute pancreatitis: Effects of a bradykinin B-2 antagonist.
FASEB J 1998 12: A260-A260.
Web of Science
** Legat, FJ; Griesbacher, T
The inflammatory response by a house dust mite extract in non-sensitized rats is caused by 5-hydroxytryptamine from mast cells.
J INVEST DERMATOL 1998 110: 652-652.
Web of Science
** Lembeck, F; Griesbacher, T
A possible contribution of endogenous kinins in exocrine and vascular functions of the pancreas
NAUNYN-SCHMIED ARCH PHARMACOL 1998 358: R784-R784.
Web of Science
** Griesbacher, T; Legat, FJ
Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
Br J Pharmacol. 1997; 120(5):933-939
Doi: 10.1038/sj.bjp.0700966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Sametz, W; Legat, FJ; Diethart, S; Hammer, S; Juan, H
Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Br J Pharmacol. 1997; 121(3):469-476
Doi: 10.1038/sj.bjp.0701159
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T
Effectivity of the B-2 antagonist FR173657 in models of acute pancreatitis and cystitis in rats
NAUNYN-SCHMIED ARCH PHARMACOL 1997 356: 186-186.
Web of Science
** Griesbacher, T
Effects of the nonpeptide bradykinin antagonist, FR173657, in experimental models of acute pancreatitis and cystitis in rats
BRIT J PHARMACOL 1997 122: U98-U98.
Web of Science
** Sametz, W; Diethart, S; Juan, H; Amann, R; Griesbacher, T
Actions of bradykinin involving the activation of primary afferent neurones inhibited by the nonpeptide B-2 receptor antagonist, FR173657.
NAUNYN-SCHMIED ARCH PHARMACOL 1997 355: 292-292.
Web of Science
** Legat, FJ; Althuber, P; Maier, R; Griesbacher, T; Lembeck, F
Evidence for the presence of NK1 and NK3 receptors on cholinergic neurones in the guinea-pig ileum.
Neurosci Lett. 1996; 207(2):125-128
Doi: 10.1016/0304-3940(96)12503-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lembeck, F; Griesbacher, T
Pathophysiological and possible physiological roles of kinins in the pancreas.
Immunopharmacology. 1996; 33(1-3):336-338
Doi: 10.1016%2F0162-3109%2896%2900102-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Legat, FJ
FR173657, a new, potent and selective nonpeptide bradykinin antagonist: In vivo studies
NAUNYN-SCHMIED ARCH PHARMACOL 1996 354: 23-23.
Web of Science
** Griesbacher, T; Legat, FJ
The pharmacology of FR173657, a new, potent and selective non-peptide bradykinin antagonist: In vivo studies in rats and guinea-pigs
BRIT J PHARMACOL 1996 119: P309-P309.
Web of Science
** Griesbacher, T; Rainer, I; Griengl, S
Contribution of 5-hydroxytryptamine release from mast cells to rat paw oedema induced by wasp venom and synthetic kinins
BRIT J PHARMACOL 1996 117: P89-P89.
Web of Science
** Legat, FJ; Sametz, W; Diethart, S; Hammer, S; Griesbacher, T
The pharmacology of FR173657, a new, potent and selective non-peptide bradykinin antagonist: In vitro studies in guinea-pig, rat and rabbit tissues
BRIT J PHARMACOL 1996 119: P308-P308.
Web of Science
** Legat, FJ; Sametz, W; Diethart, S; Hammer, S; Griesbacher, T
FR173657, a new, potent and selective nonpeptide bradykinin antagonist: In vitro studies
NAUNYN-SCHMIED ARCH PHARMACOL 1996 354: 24-24.
Web of Science
** Griesbacher, T; Kolbitsch, C; Tiran, B; Lembeck, F
Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after caerulein-induced pancreatitis in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(5):557-564
Doi: 10.1007%2FBF00169391
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T
Blood pressure reflexes following activation of capsaicin-sensitive afferent neurones in the biliopancreatic duct of rats.
Br J Pharmacol. 1994; 111(2):547-554
Doi: 10.1111/j.1476-5381.1994.tb14772.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Griesbacher, T; Sutliff, RL; Lembeck, F
Anti-inflammatory and analgesic activity of the bradykinin antagonist, icatibant (Hoe 140), against an extract from Porphyromonas gingivalis.
BRIT J PHARMACOL. 1994; 112(4): 1004-1006.
Doi: 10.1111/j.1476-5381.1994.tb13182.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Griesbacher, T; Lembeck, F
Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
Br J Pharmacol. 1994; 112(2):453-460
Doi: 10.1111/j.1476-5381.1994.tb13094.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Tiran, B; Lembeck, F
Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140.
Br J Pharmacol. 1993; 108(2):405-411
Doi: 10.1111/j.1476-5381.1993.tb12817.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T
Kinin-induced relaxations of the rat duodenum.
Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(1):102-107
Doi: 10.1007/BF00167578
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Donnerer, J; Legat, FJ; Lembeck, F
CP-96,345, a non-peptide antagonist of substance P: II. Actions on substance P-induced hypotension and bronchoconstriction, and on depressor reflexes in mammals.
Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(3):323-327
Doi: 10.1007/BF00173546
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Lembeck, F
Analysis of the antagonistic actions of HOE 140 and other novel bradykinin analogues on the guinea-pig ileum.
Eur J Pharmacol. 1992; 211(3):393-398
Doi: 10.1016%2F0014-2999%2892%2990397-M
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Lembeck, F
Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis.
Br J Pharmacol. 1992; 107(2):356-360
Doi: 10.1111/j.1476-5381.1992.tb12751.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Legat, FJ; Griesbacher, T; Lembeck, F
CP-96,345, a non-peptide antagonist of substance P: I. Effects on the actions mediated by substance P and related tachykinins on the guinea-pig ileum and rabbit jejunum.
Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(3):315-322
Doi: 10.1007/BF00173545
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lembeck, F; Griesbacher, T; Legat, FJ
Lack of significant unspecific effects of HOE 140 and other novel bradykinin antagonists in vitro and in vivo.
Agents Actions Suppl. 1992; 38 ( Pt 2)(3):414-422
PubMed
Google Scholar
** Lembeck, F; Griesbacher, T; Eckhardt, M; Henke, S; Breipohl, G; Knolle, J
New, long-acting, potent bradykinin antagonists.
Br J Pharmacol. 1991; 102(2):297-304
Doi: 10.1111/j.1476-5381.1991.tb12169.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lembeck, F; Griesbacher, T
Functional analysis of kinin antagonists.
J Cardiovasc Pharmacol. 1990; 15 Suppl 6(3):S75-S77
Doi: 10.1097/00005344-199000156-00014
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lembeck, F; Griesbacher, T; Eckhardt, M
Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
Br J Pharmacol. 1990; 100(1):49-54
Doi: 10.1111/j.1476-5381.1990.tb12050.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Lembeck, F; Saria, A
Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation.
Br J Pharmacol. 1989; 96(3):531-538
Doi: 10.1111/j.1476-5381.1989.tb11850.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Leighton, GE; Griesbacher, T; Hill, RG; Hughes, J
Antagonism of central and peripheral anorectic effects of caerulein by L-364,718.
Eur J Pharmacol. 1989; 161(2-3):255-258
Doi: 10.1016/0014-2999(89)90855-8
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Griesbacher, T; Lembeck, F
Effect of bradykinin antagonists on bradykinin-induced plasma extravasation, venoconstriction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit.
Br J Pharmacol. 1987; 92(2):333-340
Doi: 10.1111/j.1476-5381.1987.tb11328.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar